Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.2M Sell
88,341
-19,401
-18% -$4.02M 0.03% 348
2026
Q1
$24.2M Buy
107,742
+606
+0.6% +$151K 0.06% 263
2025
Q4
$25.8M Sell
107,136
-54,410
-34% -$13.9M 0.06% 261
2025
Q3
$44.2M Sell
161,546
-27,266
-14% -$7.45M 0.11% 157
2025
Q2
$48.7M Buy
188,812
+85,306
+82% +$20.3M 0.12% 147
2025
Q1
$23.2M Sell
103,506
-36,620
-26% -$8.55M 0.07% 226
2024
Q4
$32M Sell
140,126
-54,475
-28% -$13.1M 0.1% 187
2024
Q3
$47.5M Buy
194,601
+24,221
+14% +$5.41M 0.16% 122
2024
Q2
$32.6M Sell
170,380
-21,485
-11% -$4.36M 0.12% 153
2024
Q1
$38M Buy
+191,865
New +$35.2M 0.12% 160

Other funds holding RMD

Danske Bank's RMD Position: Q2 2026 in Review

Danske Bank reduced its ResMed (RMD) stake by 18% in Q2 2026, selling an estimated $4.02M and leaving 88,341 shares worth $17.2M. The position accounts for 0.03% of the portfolio, ranked #348.

Danske Bank first reported a position in RMD in Q1 2024 and has held it in 10 quarters since. The position peaked at $48.7M in Q2 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Danske Bank held 88,341 shares of ResMed worth $17.2M as of Q2 2026.
  • Danske Bank sold 19,401 ResMed shares in Q2 2026, an estimated $4.02M.
  • ResMed made up 0.03% of Danske Bank's portfolio in Q2 2026, its #348 holding.
  • Danske Bank first reported a position in ResMed in Q1 2024 and has held it in 10 quarters since.
  • Danske Bank's ResMed position peaked at $48.7M in Q2 2025.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.